| Item Type | Name |
|
Concept
|
Abdominal Neoplasms
|
|
Concept
|
Acetylation
|
|
Concept
|
Antibodies, Bacterial
|
|
Concept
|
Adrenal Gland Neoplasms
|
|
Concept
|
Ataxia
|
|
Concept
|
Alabama
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Animals
|
|
Concept
|
Antimetabolites, Antineoplastic
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Antiviral Agents
|
|
Concept
|
Chromosomes, Human, Pair 11
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Anti-Inflammatory Agents
|
|
Concept
|
Cell Movement
|
|
Concept
|
Body Height
|
|
Concept
|
Bone Neoplasms
|
|
Concept
|
Biopsy
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Chromosomes, Human, Pair 1
|
|
Concept
|
Chicago
|
|
Concept
|
Ganglioneuroma
|
|
Concept
|
Contraceptive Agents, Female
|
|
Concept
|
DNA-Binding Proteins
|
|
Concept
|
DNA, Mitochondrial
|
|
Concept
|
Immunosuppressive Agents
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Decision Support Techniques
|
|
Concept
|
DNA Repair
|
|
Concept
|
Cyclophosphamide
|
|
Concept
|
Europe
|
|
Concept
|
Chromosomes, Human, Pair 17
|
|
Concept
|
Etoposide
|
|
Concept
|
Ferritins
|
|
Concept
|
Infant, Newborn
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Neovascularization, Pathologic
|
|
Concept
|
Neurologic Examination
|
|
Concept
|
Karyotyping
|
|
Concept
|
DNA (Cytosine-5-)-Methyltransferases
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Liver Neoplasms
|
|
Concept
|
Pelvic Neoplasms
|
|
Concept
|
Hydroxamic Acids
|
|
Concept
|
Image Interpretation, Computer-Assisted
|
|
Concept
|
Gene Amplification
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Mitotic Index
|
|
Concept
|
Pilot Projects
|
|
Concept
|
Mice, Transgenic
|
|
Concept
|
Models, Genetic
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Palliative Care
|
|
Concept
|
Mice, Nude
|
|
Concept
|
Morbidity
|
|
Concept
|
Mumps virus
|
|
Concept
|
L-Lactate Dehydrogenase
|
|
Concept
|
Cholesterol, HDL
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Orbital Neoplasms
|
|
Concept
|
Melphalan
|
|
Concept
|
Patient Acceptance of Health Care
|
|
Concept
|
Peripheral Nervous System Neoplasms
|
|
Concept
|
Pheochromocytoma
|
|
Concept
|
Phenylurea Compounds
|
|
Concept
|
Motivation
|
|
Concept
|
Neoplasms, Muscle Tissue
|
|
Concept
|
Prednisone
|
|
Concept
|
Pregnancy Outcome
|
|
Concept
|
Protease Inhibitors
|
|
Concept
|
Gangliosides
|
|
Concept
|
Immunoenzyme Techniques
|
|
Concept
|
Infant, Low Birth Weight
|
|
Concept
|
Radiation Injuries
|
|
Concept
|
Recurrence
|
|
Concept
|
Head and Neck Neoplasms
|
|
Concept
|
Radiation-Sensitizing Agents
|
|
Concept
|
Risk Factors
|
|
Concept
|
Quality of Life
|
|
Concept
|
Soft Tissue Neoplasms
|
|
Concept
|
Retroperitoneal Neoplasms
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Health Knowledge, Attitudes, Practice
|
|
Concept
|
Risk
|
|
Concept
|
Humans
|
|
Concept
|
Incidence
|
|
Concept
|
Cluster Analysis
|
|
Concept
|
Tretinoin
|
|
Concept
|
Thoracic Neoplasms
|
|
Concept
|
International Agencies
|
|
Concept
|
United States
|
|
Concept
|
Wernicke Encephalopathy
|
|
Concept
|
Iodine Radioisotopes
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Mycobacterium avium-intracellulare Infection
|
|
Concept
|
Oncogene Proteins, Fusion
|
|
Concept
|
Proportional Hazards Models
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Risk Assessment
|
|
Concept
|
Radiopharmaceuticals
|
|
Concept
|
Myeloablative Agonists
|
|
Concept
|
Central Nervous System Neoplasms
|
|
Concept
|
Receptors, Interleukin-2
|
|
Concept
|
Lymph Nodes
|
|
Concept
|
Lymphatic Metastasis
|
|
Concept
|
Lymphoma
|
|
Concept
|
Leukemia, Myeloid, Acute
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Stem Cell Transplantation
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Age Distribution
|
|
Concept
|
Medical Oncology
|
|
Concept
|
Melanoma
|
|
Concept
|
Ecosystem
|
|
Concept
|
Paraffin Embedding
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasm Recurrence, Local
|
|
Concept
|
Tissue Fixation
|
|
Concept
|
Gene Deletion
|
|
Concept
|
Ganglioneuroblastoma
|
|
Concept
|
Disease Progression
|
|
Concept
|
Immunomagnetic Separation
|
|
Concept
|
Fluorodeoxyglucose F18
|
|
Concept
|
3-Iodobenzylguanidine
|
|
Concept
|
Antineoplastic Agents, Alkylating
|
|
Concept
|
Limbic Encephalitis
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Multidrug Resistance-Associated Proteins
|
|
Concept
|
Opsoclonus-Myoclonus Syndrome
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
Bone Marrow Neoplasms
|
|
Concept
|
In Situ Hybridization, Fluorescence
|
|
Concept
|
Watchful Waiting
|
|
Concept
|
Fatal Outcome
|
|
Concept
|
Topoisomerase I Inhibitors
|
|
Concept
|
Hepatitis A Antibodies
|
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Neoplasms, Complex and Mixed
|
|
Concept
|
Response Elements
|
|
Concept
|
Parents
|
|
Concept
|
Oligonucleotide Array Sequence Analysis
|
|
Concept
|
Lactic Acid
|
|
Concept
|
Loss of Heterozygosity
|
|
Concept
|
Interdisciplinary Communication
|
|
Concept
|
Pregnancy Complications, Infectious
|
|
Concept
|
Mice
|
|
Concept
|
Pyrazoles
|
|
Concept
|
Surveys and Questionnaires
|
|
Concept
|
Health Status Disparities
|
|
Concept
|
Severity of Illness Index
|
|
Concept
|
Research Design
|
|
Concept
|
RNA, Messenger
|
|
Concept
|
Receptors, KIR3DL1
|
|
Concept
|
Sulfonamides
|
|
Concept
|
Anti-Retroviral Agents
|
|
Concept
|
Norepinephrine Plasma Membrane Transport Proteins
|
|
Concept
|
Real-Time Polymerase Chain Reaction
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Models, Statistical
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Logistic Models
|
|
Concept
|
Survival Analysis
|
|
Concept
|
Genes, myc
|
|
Concept
|
DNA Copy Number Variations
|
|
Concept
|
Drug Monitoring
|
|
Concept
|
Reproducibility of Results
|
|
Concept
|
Treatment Failure
|
|
Concept
|
Survival Rate
|
|
Concept
|
Azithromycin
|
|
Concept
|
Odds Ratio
|
|
Concept
|
Polymerase Chain Reaction
|
|
Concept
|
Patient Selection
|
|
Concept
|
Immunoglobulins, Intravenous
|
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
SEER Program
|
|
Concept
|
CD4 Lymphocyte Count
|
|
Concept
|
Pregnancy Rate
|
|
Concept
|
Microsatellite Repeats
|
|
Concept
|
Anti-HIV Agents
|
|
Concept
|
MAP Kinase Signaling System
|
|
Concept
|
Nomograms
|
|
Concept
|
Tubulin Modulators
|
|
Concept
|
Receptors, KIR2DL1
|
|
Concept
|
Genome-Wide Association Study
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Kaplan-Meier Estimate
|
|
Concept
|
Comparative Genomic Hybridization
|
|
Concept
|
Intention to Treat Analysis
|
|
Concept
|
Anti-Bacterial Agents
|
|
Concept
|
Antibodies
|
|
Concept
|
Benzenesulfonates
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Chromosome Aberrations
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Cytosine
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Hepatomegaly
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Lymphoma, Non-Hodgkin
|
|
Concept
|
Magnetic Resonance Imaging
|
|
Concept
|
Models, Biological
|
|
Concept
|
Neoplasm Invasiveness
|
|
Concept
|
Neuroblastoma
|
|
Concept
|
Niacinamide
|
|
Concept
|
Predictive Value of Tests
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Serum Albumin, Bovine
|
|
Concept
|
Sex Education
|
|
Concept
|
Translocation, Genetic
|
|
Concept
|
HIV-1
|
|
Concept
|
Granulocyte-Macrophage Colony-Stimulating Factor
|
|
Concept
|
Databases, Factual
|
|
Concept
|
Cost of Illness
|
|
Concept
|
Neoplasm, Residual
|
|
Concept
|
Disease-Free Survival
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Polymorphism, Single Nucleotide
|
|
Concept
|
Databases, Nucleic Acid
|
|
Concept
|
5-Methylcytosine
|
|
Concept
|
Protein Kinase Inhibitors
|
|
Concept
|
Receptors, KIR
|
|
Concept
|
Medication Adherence
|
|
Concept
|
Research Report
|
|
Academic Article
|
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth.
|
|
Academic Article
|
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.
|
|
Academic Article
|
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.
|
|
Academic Article
|
Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
|
|
Academic Article
|
Locoregional MYCN-amplified neuroblastoma.
|
|
Academic Article
|
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: a report from the International Neuroblastoma Risk Group Project.
|
|
Academic Article
|
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project.
|
|
Academic Article
|
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
|
|
Academic Article
|
Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone.
|
|
Academic Article
|
Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
|
|
Academic Article
|
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project.
|
|
Academic Article
|
ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.
|
|
Academic Article
|
Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
|
|
Academic Article
|
TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.
|
|
Academic Article
|
New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.
|
|
Academic Article
|
Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.
|
|
Academic Article
|
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
|
|
Academic Article
|
Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse.
|
|
Academic Article
|
Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
|
|
Academic Article
|
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.
|
|
Academic Article
|
Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.
|
|
Grant
|
Mechanisms of Pancreatic Cancer Inhibition by SPARC
|
|
Grant
|
Genome-Wide 5hmC Profiling of Neuroblastoma Tumors and Patient Cell-free DNA
|
|
Academic Article
|
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1.
|
|
Academic Article
|
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
|
|
Academic Article
|
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype.
|
|
Academic Article
|
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
|
|
Academic Article
|
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
|
|
Grant
|
Targeting DNA Double Strand Break (DSB) Repair Pathways Neuroblastoma
|
|
Academic Article
|
Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
|
|
Academic Article
|
Repeat pregnancies among HIV-infected women enrolled in clinical trial PACTG1022.
|
|
Academic Article
|
Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis.
|
|
Academic Article
|
MYCN and HIF-1 directly regulate TET1 expression to control 5-hmC gains and enhance neuroblastoma cell migration in hypoxia.
|
|
Concept
|
Clinical Decision-Making
|
|
Concept
|
Rituximab
|
|
Concept
|
Filgrastim
|
|
Concept
|
N-Myc Proto-Oncogene Protein
|
|
Concept
|
Antineoplastic Agents, Immunological
|
|
Concept
|
Response Evaluation Criteria in Solid Tumors
|
|
Academic Article
|
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
|
|
Academic Article
|
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
|